Literature DB >> 27225761

Catecholamine-Mediated Increases in Gain Enhance the Precision of Cortical Representations.

Christopher M Warren1, Eran Eldar2, Ruud L van den Brink3, Klodianna-Daphne Tona3, Nic J van der Wee4, Eric J Giltay5, Martijn S van Noorden5, Jos A Bosch6, Robert C Wilson7, Jonathan D Cohen3, Sander Nieuwenhuis8.   

Abstract

UNLABELLED: Neurophysiological evidence suggests that neuromodulators, such as norepinephrine and dopamine, increase neural gain in target brain areas. Computational models and prominent theoretical frameworks indicate that this should enhance the precision of neural representations, but direct empirical evidence for this hypothesis is lacking. In two functional MRI studies, we examine the effect of baseline catecholamine levels (as indexed by pupil diameter and manipulated pharmacologically) on the precision of object representations in the human ventral temporal cortex using angular dispersion, a powerful, multivariate metric of representational similarity (precision). We first report the results of computational model simulations indicating that increasing catecholaminergic gain should reduce the angular dispersion, and thus increase the precision, of object representations from the same category, as well as reduce the angular dispersion of object representations from distinct categories when distinct-category representations overlap. In Study 1 (N = 24), we show that angular dispersion covaries with pupil diameter, an index of baseline catecholamine levels. In Study 2 (N = 24), we manipulate catecholamine levels and neural gain using the norepinephrine transporter blocker atomoxetine and demonstrate consistent, causal effects on angular dispersion and brain-wide functional connectivity. Despite the use of very different methods of examining the effect of baseline catecholamine levels, our results show a striking convergence and demonstrate that catecholamines increase the precision of neural representations. SIGNIFICANCE STATEMENT: Norepinephrine and dopamine are among the most widely distributed and ubiquitous neuromodulators in the mammalian brain and have a profound and pervasive impact on cognition. Baseline catecholamine levels tend to increase with increasing task engagement in tasks involving perceptual decisions, yet there is currently no direct evidence of the specific impact of these increases in catecholamine levels on perceptual encoding. Our results fill this void by showing that catecholamines enhance the precision of encoding cortical object representations, and by suggesting that this effect is mediated by increases in neural gain, thus offering a mechanistic account of our key finding.
Copyright © 2016 the authors 0270-6474/16/365699-10$15.00/0.

Entities:  

Keywords:  catecholamine; dopamine; fMRI; norepinephrine; perception; psychopharmacology

Mesh:

Substances:

Year:  2016        PMID: 27225761      PMCID: PMC6601838          DOI: 10.1523/JNEUROSCI.3475-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Cortisol fluctuates with increases and decreases in negative affect.

Authors:  T W Buchanan; M al'Absi; W R Lovallo
Journal:  Psychoneuroendocrinology       Date:  1999-02       Impact factor: 4.905

2.  Modulation of attention by noradrenergic alpha2-agents varies according to arousal level.

Authors:  J T Coull
Journal:  Drug News Perspect       Date:  2001-02

Review 3.  A matter of focus: monoaminergic modulation of stimulus coding in mammalian sensory networks.

Authors:  L M Hurley; D M Devilbiss; B D Waterhouse
Journal:  Curr Opin Neurobiol       Date:  2004-08       Impact factor: 6.627

4.  Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Authors:  Frank P Bymaster; Jason S Katner; David L Nelson; Susan K Hemrick-Luecke; Penny G Threlkeld; John H Heiligenstein; S Michelle Morin; Donald R Gehlert; Kenneth W Perry
Journal:  Neuropsychopharmacology       Date:  2002-11       Impact factor: 7.853

5.  Distributed and overlapping representations of faces and objects in ventral temporal cortex.

Authors:  J V Haxby; M I Gobbini; M L Furey; A Ishai; J L Schouten; P Pietrini
Journal:  Science       Date:  2001-09-28       Impact factor: 47.728

Review 6.  The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes.

Authors:  Craig W Berridge; Barry D Waterhouse
Journal:  Brain Res Brain Res Rev       Date:  2003-04

7.  Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans.

Authors:  Jennifer T Coull; Matt E P Jones; Talmage D Egan; Chris D Frith; Mervyn Maze
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

Review 8.  Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.

Authors:  Georg Winterer; Daniel R Weinberger
Journal:  Trends Neurosci       Date:  2004-11       Impact factor: 13.837

9.  Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.

Authors:  S H Heil; H W Holmes; W K Bickel; S T Higgins; G J Badger; H F Laws; D E Faries
Journal:  Drug Alcohol Depend       Date:  2002-07-01       Impact factor: 4.492

10.  Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.

Authors:  Paola Devoto; Giovanna Flore; Luigi Pira; Giorgio Longu; Gian Luigi Gessa
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

View more
  23 in total

1.  Neuropsychopharmacological regulation of performance on creativity-related tasks.

Authors:  David Q Beversdorf
Journal:  Curr Opin Behav Sci       Date:  2018-09-27

2.  Increased locus coeruleus tonic activity causes disengagement from a patch-foraging task.

Authors:  Gary A Kane; Elena M Vazey; Robert C Wilson; Amitai Shenhav; Nathaniel D Daw; Gary Aston-Jones; Jonathan D Cohen
Journal:  Cogn Affect Behav Neurosci       Date:  2017-12       Impact factor: 3.282

3.  Two Routes to Incidental Memory under Arousal: Dopamine and Norepinephrine.

Authors:  John Thorp; David Clewett; Monika Riegel
Journal:  J Neurosci       Date:  2020-02-26       Impact factor: 6.167

4.  Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.

Authors:  Mareike Clos; Nico Bunzeck; Tobias Sommer
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

5.  Dynamic modulation of decision biases by brainstem arousal systems.

Authors:  Jan Willem de Gee; Olympia Colizoli; Niels A Kloosterman; Tomas Knapen; Sander Nieuwenhuis; Tobias H Donner
Journal:  Elife       Date:  2017-04-11       Impact factor: 8.140

Review 6.  Fluid intelligence and the locus coeruleus-norepinephrine system.

Authors:  Jason S Tsukahara; Randall W Engle
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-16       Impact factor: 11.205

7.  Dopamine is a double-edged sword: dopaminergic modulation enhances memory retrieval performance but impairs metacognition.

Authors:  Mareike Clos; Nico Bunzeck; Tobias Sommer
Journal:  Neuropsychopharmacology       Date:  2018-10-25       Impact factor: 7.853

8.  Isometric exercise facilitates attention to salient events in women via the noradrenergic system.

Authors:  Mara Mather; Ringo Huang; David Clewett; Shawn E Nielsen; Ricardo Velasco; Kristie Tu; Sophia Han; Briana L Kennedy
Journal:  Neuroimage       Date:  2020-01-21       Impact factor: 6.556

9.  Pharmacological Fingerprints of Contextual Uncertainty.

Authors:  Louise Marshall; Christoph Mathys; Diane Ruge; Archy O de Berker; Peter Dayan; Klaas E Stephan; Sven Bestmann
Journal:  PLoS Biol       Date:  2016-11-15       Impact factor: 8.029

10.  Global gain modulation generates time-dependent urgency during perceptual choice in humans.

Authors:  Peter R Murphy; Evert Boonstra; Sander Nieuwenhuis
Journal:  Nat Commun       Date:  2016-11-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.